Literature DB >> 16497210

T-cell responses during pig-to-primate xenotransplantation.

Eduardo Davila1, Guerard W Byrne, Peter T LaBreche, Hugh C J McGregor, Allison K Schwab, William R Davies, Vinay P Rao, Keiji Oi, Henry D Tazelaar, John S Logan, Christopher G A McGregor.   

Abstract

UNLABELLED: Xenotransplantation using porcine organs may resolve a chronic shortage of donor organs for clinical transplantation if significant immunological barriers can be overcome. To determine the potential role of T lymphocytes in Xenograft (Xg) rejection, we transplanted transgenic hCD46 porcine hearts heterotopically into baboon recipients.
METHODS: Recipients were treated to deplete anti-Gal antibody with a non-antigenic alpha-Gal polyethylene glycol polymer (TPC) (n = 2), TPC plus rituximab (anti-CD20) (n = 1) or were untreated (n = 1). None of the recipients received T-cell immunosuppression.
RESULTS: All Xgs failed within 7 days and showed evidence of a mixed humoral and cellular rejection process. Cellular infiltration consisting primarily of CD4+ T cells and few CD8+ T cells. Proliferation and cytotoxicity assays showed sensitization of CD4+ and CD8+ T cells that reacted with porcine IFN-gamma (pIFN-gamma)-stimulated porcine aortic endothelial cells (PAEC). The CD4+ lymphocytes displayed greater cytotoxicity than CD8+ cells. An increased frequency of PAEC-specific interleukin (IL) 2 and IFN-gamma-secreting T cells was observed, suggesting a Th1 cytokine bias. An increase in the percentage of circulating CD4+CD28- cells was observed at the time of rejection and over 50% of the CD4+ cells recovered from residual pig tissue at necropsy lacked CD28 expression.
CONCLUSIONS: These findings show that lymphocytes are efficiently stimulated by PAEC antigens and can mediate direct tissue destruction. These studies (1) provide an insight into the potential of cellular-mediated cardiac Xg rejection, (2) show for the first time the induction of cytotoxic pig-specific CD4+CD28- lymphocytes and (3) provide a rational basis for determining different modes of immunosuppression to treat Xg rejection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497210     DOI: 10.1111/j.1399-3089.2005.00258.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  26 in total

Review 1.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

Review 2.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

3.  Reduced positive selection of a human TCR in a swine thymus using a humanized mouse model for xenotolerance induction.

Authors:  Grace Nauman; Chiara Borsotti; Nichole Danzl; Mohsen Khosravi-Maharlooei; Hao-Wei Li; Estefania Chavez; Samantha Stone; Megan Sykes
Journal:  Xenotransplantation       Date:  2019-09-29       Impact factor: 3.907

4.  Relative efficiency of porcine and human cytotoxic T-lymphocyte antigen 4 immunoglobulin in inhibiting human CD4+ T-cell responses co-stimulated by porcine and human B7 molecules.

Authors:  Tadatsura Koshika; Carol Phelps; Jason Fang; Seung Eun Lee; Minoru Fujita; David Ayares; David K C Cooper; Hidetaka Hara
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

Review 5.  New concepts of immune modulation in xenotransplantation.

Authors:  Vikas Satyananda; Hidetaka Hara; Mohamed B Ezzelarab; Carol Phelps; David Ayares; David K C Cooper
Journal:  Transplantation       Date:  2013-12-15       Impact factor: 4.939

6.  Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion.

Authors:  Steven C Kim; David V Mathews; Cynthia P Breeden; Laura B Higginbotham; Joseph Ladowski; Gregory Martens; Allison Stephenson; Alton B Farris; Elizabeth A Strobert; Joe Jenkins; Eric M Walters; Christian P Larsen; Matthew Tector; Alfred J Tector; Andrew B Adams
Journal:  Am J Transplant       Date:  2019-04-05       Impact factor: 8.086

7.  Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation.

Authors:  Guerard W Byrne; Paul G Stalboerger; Eduardo Davila; Carrie J Heppelmann; Mozammel H Gazi; Hugh C J McGregor; Peter T LaBreche; William R Davies; Vinay P Rao; Keiji Oi; Henry D Tazelaar; John S Logan; Christopher G A McGregor
Journal:  Xenotransplantation       Date:  2008 Jul-Aug       Impact factor: 3.907

8.  Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells.

Authors:  Agnes M Azimzadeh; Guerard W Byrne; Mohamed Ezzelarab; Emily Welty; Gheorghe Braileanu; Xiangfei Cheng; Simon C Robson; Christopher G A McGregor; David K C Cooper; Richard N Pierson
Journal:  Xenotransplantation       Date:  2014-09-01       Impact factor: 3.907

Review 9.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

10.  Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons.

Authors:  Y Hisashi; K Yamada; K Kuwaki; Y-L Tseng; F J M F Dor; S L Houser; S C Robson; H-J Schuurman; D K C Cooper; D H Sachs; R B Colvin; A Shimizu
Journal:  Am J Transplant       Date:  2008-12       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.